Physician profile
Michael Easterling
NPI 1720154768
$1,391.17
in general payments reported to CMS, 2019-2025
20 companies · $424 in 2025
The $424 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $106 · 2023: $319 · 2024: $417 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $382.12 | 2022-2025 | Penditure, Avalus, Mosaic |
| Atricure, INC. | $271.36 | 2022-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $114.55 | 2021-2025 | Sapien 3 Ultra Resilia, Konect Resilia, Mitris Resilia Mitral Valve |
| Chiesi USA, INC. | $91.89 | 2021-2024 | Cleviprex |
| Ethicon US, LLC | $77.03 | 2023-2025 | Echelon; Endopath, Vistaseal, Ethicon |
| Artivion, INC. | $56.40 | 2023-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Photofix Decellularized Bovine Pericardium, Amds-Ascyrus Medical |
| Elutia, INC. | $52.83 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $45.10 | 2024-2025 | |
| Intuitive Surgical, INC. | $42.98 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $29.65 | 2024 | Imfinzi |
| Baxter Healthcare | $29.40 | 2021 | |
| Abbott Laboratories | $27.19 | 2023 | Epic |
| Kci USA, INC. | $27.16 | 2021 | |
| Inspire Medical Systems, INC. | $26.14 | 2025 | Inspire |
| Getinge USA Sales, LLC | $25.68 | 2025 | Vasoview Hemopro 2 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $23.34 | 2024 | Teg6s Hemostasis System |
| Smith+Nephew, INC. | $20.93 | 2023 | Grafix Pl |
| Ge Healthcare | $18.08 | 2024 | |
| Stryker Corporation | $16.38 | 2024 | Na |
| Boston Scientific Corporation | $12.96 | 2023 | Artisan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Easterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.